Safety Profile of Tyrosine Kinase Inhibitors Approved for Gastrointestinal Stromal Tumors: Analysis from the European Spontaneous Adverse Event Reporting System Conference

Barbieri, MA, Sorbara, EE, Santoro, V et al. (2022). Safety Profile of Tyrosine Kinase Inhibitors Approved for Gastrointestinal Stromal Tumors: Analysis from the European Spontaneous Adverse Event Reporting System . 45(10), 1157-1158.

cited authors

  • Barbieri, MA; Sorbara, EE; Santoro, V; Cicala, G; Cutroneo, PM; Santarpia, M; Franchina, T; Silvestris, N; Spina, E

sustainable development goals

authors

date/time interval

  • September 20, 2022 -

publication date

  • October 1, 2022

keywords

  • Life Sciences & Biomedicine
  • Pharmacology & Pharmacy
  • Public, Environmental & Occupational Health
  • Science & Technology
  • Toxicology

Location

  • ITALY, Verona

Conference

  • 21st ISoP Annual Meeting on New Era of Pharmacovigilance - Challenges and Opportunities

publisher

  • ADIS INT LTD

start page

  • 1157

end page

  • 1158

volume

  • 45

issue

  • 10